Anti-GPR146 Antibody, clone 1F6 ZooMAb^® Rabbit Monoclonal

200

rabbit

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

1F6, recombinant monoclonal

recombinant, expressed in HEK 293 cells

ZooMAb^® learn more

lyophilized

calculated mol wt 36.58 kDa
observed mol wt ~36 kDa

using Protein A

rat, mouse, human

monkey

antibody small pack of 25 μL

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunocytochemistry: suitable
western blot: suitable

IgG

C-terminal half

NP_001290402

Q96CH1

ambient

2-8℃

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

Clone 1F6 is a Rabbit recombinant monoclonal antibody that specifically detects GPR146. It targets an epitope within 23 amino acids from the third cytoplasmic domain within the C-terminal half.

KLH-conjugated linear peptide corresponding to 23 amino acids from the third cytoplasmic domain within the C-terminal region of human GPR146.

Quality Control Testing

Evaluated by Western Blotting in mouse liver tissue lysate.

Western Blotting Analysis: A 1:10,000 dilution of this antibody detected GPR146 in mouse liver tissue lysate.

Tested applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected GPR146 in human liver and 1:10,000 dilution in rat liver tissue lysates.

Affinity Binding Assay: A representative lot of this antibody bound GPR146 with a KD of 8.0 x 10-8 in an affinity binding assay.

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected GPR146 in LoVo cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Probable G-protein coupled receptor 146 (UniProt: Q96CH1; also known as G-protein coupled receptor PGR8, GPR146) is encoded by the GPR146 (also known as PGR8) gene (Gene ID: 115330) in human. GPR146 is a multi-pass membrane protein with four extracellular domains, seven transmembrane domains, and four cytoplasmic domains. It is reported to promote the activity of hepatic sterol regulatory element binding protein 2 (SREBP2) via activation of the ERK signaling pathway that regulates hepatic very low-density lipoprotein (VLDL) secretion, and subsequently reduces the circulating levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) levels. Deficiency of GPR146 is shown to reduce hepatic SREBP2 activity and VLDL secretion rate. This significantly reduces plasma cholesterol levels in both wild-type and LDL receptor-deficient mice. Mice deficient in GPR146 are shown to have significantly reduced aortic atherosclerotic lesions. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Yu, H., et al. (2019). Cell. 179(6); 1276-1288).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

13 - Non Combustible Solids

WGK 1